期刊文献+

乙肝患者血清sICAM-1检测的临床意义 被引量:1

Serum Levels of Soluble Intercellular Adhesion Molecule-1 in Patients with Viral Hepatitis B and Clinical Significance of Its Detection
下载PDF
导出
摘要 目的探讨乙型肝炎患者血清可溶性细胞间粘附分子 1(sICAM 1)水平与肝损害的关系。方法采用双抗体夹心ELISA法。检测 2 0例正常人和 6 7例HBV感染患者血清sICAM 1。结果轻、中、重度慢性乙型肝炎 (CH)患者及重型乙型肝炎 (SH)早、中、晚期患者血清sICAM 1水平 ,均显著高于正常人 ;CH患者肝功能越差、其血清sICAM 1水平越高 ;SH患者肝衰竭越重 ,其血清sICAM 1水平反而越低。HBeAg阳性或HBVDNA阳性的乙肝患者血清sICAM 1水平与HBeAg阴性和HBVDNA阴性的乙肝患者相比差异无显著性。结论在CH和SH早期 ,乙肝患者血清sICAM 1水平随着患者肝损害的加重而升高。重型肝炎患者血清sICAM 1水平随着患者肝衰竭的加重而降低 ,故sICAM Objectives To explore the relationship between serum levels of soluble intercellular adhesion molecule 1(sICAM 1) and liver damage in patients with viral hepatitis B.Methods Serum levels of sICAM 1 were measured by double antibody sandwich ELISA technique in 20 healthy donors and 67 patients with HBV infection.Results The serum levels of sICAM 1 in patients with chronic hepatitis B(CH; mild, moderate and severe grades), and critical viral hepatitis B (SH) patients in their early, intermediate and late stages were all significantly higher than those of healthy controls. The worse the liver function in CH patients, the higher were serum levels of sICAM 1;the more severe the failure of liver function in SH patients, the lower would be their serum levels of sICAM 1. As compared with the serum levels of sICAM 1 in CH patients with negative HBeAg and HBV DNA, those in CH patients with positive HBeAg and HBV DNA revealed no significant difference. Conclusion The serum levels of sICAM 1 in the early stage of CH and SH increase gradually with the aggravation of live damage, whereas those in SH patients decrease when failure of their liver function becomes worse. Therefore, sICAM can be used as a clinical criterion for monitoring the severity of viral hepatitis B and degree of liver damage.
出处 《医学临床研究》 CAS 2003年第1期13-15,共3页 Journal of Clinical Research
基金 福建省科委资助课题 (99 Z 14 )
关键词 肝炎 乙型 血液 胞间粘附分子1 hepatitis B/BL intercellular adhesion molecule-1/BL
  • 相关文献

参考文献1

共引文献6

同被引文献9

  • 1Autschbach F;Meuer SC;Moebius U.Hepatocellular expression of lymphocyte function-associated antigen 3 in chronic hepatitis,1991(02).
  • 2Thomson AW;Satoh S;Nussler AK.Circulating intercellular adhesion molecule-1 (ICAM-1) in autoimmune liver disease and evidence for the production of ICAM-1 by cytokine-stimulated hepatocyte[J],1994.
  • 3Lie YS;Petropoulos CJ.Advances in quantitative PCR technology: 5' nuclease assays[J],1998(1).
  • 4Whitcombe D;Theaker J;Guy SP.Detection of PCR products using self-probing amplicons and fluorescence[J],1999(08).
  • 5Yin JL;Shackel NA;Zekry A.Real time reverse transcriptase polymerase chain reaction ( RT-PC ) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green Ⅰ[J],2001(03).
  • 6Le Guiner S;Le Drean E;Labarriere N.LFA-3 costimulates cytokine secretion by cytotoxic T lymphocytes by providing a TCR-independent activation signal[J],1998(04).
  • 7Lopez RD;Waller EK;Lu PH.CD58/LFA 3 and IL-12provided by activated monocytes are critical in the in vitro expansion of CD56 + T cells,2001.
  • 8SangKon Oh;James W.Hodge;Jeffrey D.Ahlers.Selective induction of high avidity CTL by altering the balance of signals from APC[J],2003.
  • 9张绪清,张瑞,顾长海,王宇明.乙型肝炎肝内ICAM-1和HLA-A,B,C表达的研究[J].第三军医大学学报,2001,23(7):841-843. 被引量:4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部